Dotatate Recruiting Phase 2 Trials for VHL Pancreatic Neuroendocrine Tumors / Von Hippel Lindau Disease / Neuroendocrine Tumours (NETs) Diagnostic

IndicationsStatusPurposePhase
RecruitingDiagnostic2
clinicaltrials.gov IdentifierTitleDrugs
NCT04074135Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors